Cas:241139-32-2 (5R)-5-(Methoxymethyl)-1,3-oxazolidin-2-one manufacturer & supplier

Chemical Name:(5R)-5-(Methoxymethyl)-1,3-oxazolidin-2-one

CAS.NO:241139-32-2

Synonyms:(5R)-5-(Methoxymethyl)-1,3-oxazolidin-2-one

Molecular Formula:C₅H₉NO₃

Molecular Weight:131.13000

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:51.05000

Exact Mass:131.05800

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (5R)-5-(Methoxymethyl)-1,3-oxazolidin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(5R)-5-(Methoxymethyl)-1,3-oxazolidin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(5R)-5-(Methoxymethyl)-1,3-oxazolidin-2-one Use and application,(5R)-5-(Methoxymethyl)-1,3-oxazolidin-2-one technical grade,usp/ep/jp grade.

Related News: As one of the world’s largest API producers and exporters, China’s chemical API production and operating income show steady growth. (5R)-5-(Methoxymethyl)-1,3-oxazolidin-2-one manufacturer Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control. (5R)-5-(Methoxymethyl)-1,3-oxazolidin-2-one supplier Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control. (5R)-5-(Methoxymethyl)-1,3-oxazolidin-2-one vendor Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant. (5R)-5-(Methoxymethyl)-1,3-oxazolidin-2-one factory Countries and territories that have confirmed cases: Thailand, Japan, Hong Kong, Singapore, Taiwan, Australia, Malaysia, Macau, Russia, France, the United States, South Korea, Germany, the United Arab Emirates, Canada, Britain, Vietnam, Italy, India, the Philippines, Nepal, Cambodia, Sri Lanka, Finland, Sweden and Spain.